AdvVEGF-D therapy

N/A

Report date: 2023/10/26 16:03:23

Base Information

Drug NameAdvVEGF-D therapy
Drug Alias NameAdvVEGF-DEG-013Ad.VEGF-DdeltaNdeltaC
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionVascular endothelial growth factor A stimulants
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Eastern Finland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Eastern Finland
Active IndicationsN/A
Inactive IndicationsAngina Pectoris

Other Information

ATC CodeN/A
Related LinksN/A